Healthera, the leading patient experience platform, has secured £2 million in strategic investment from a consortium of private and health-tech investors, boosting its current Series A round to £5.6 million and accelerating its mission to transform digital pharmacy services.
With a sustainable foundation set in 2024, the company - which already provides technology for over 1,700 UK pharmacies and over a million patients - is now poised for significant expansion across the UK and North America and into new revenue verticals, including private medicine prescribing and the end-to-end management of clinical services.
Founded at Cambridge University, Healthera is the UK's most-popular digital pharmacy platform connecting patients with the medicines and healthcare services they need. In 2024, Healthera processed over 5 million digital prescriptions, with partners outperforming the market by 10%.
This funding round was completed by private investors through the network of Committed Capital, who led the investment.
Previous investors in Healthera include Cambridge Enterprise, Accelerated Digital Ventures (Legal and General), NHS England and Innovate UK.
